This is a mobile optimized page that loads fast, if you want to load the real page, click this text.

BNO - Bionomics Limited

tech/a

No Ordinary Duck
Joined
14 October 2004
Posts
20,446
Reactions
6,471
This has flown under the radar ---no thread found

 
Re: BNO - Bionomics

This one shot up and came down with a bang.
Now the trend is upswing. Reading the presentation from company my guess is that there are something good going to happen by early 2015. Patience is required . However this medico shares are like oil drill - boom or bust.
http://hfgapps.hubb.com/asxtools/imageChart.axd?TF=D6&TIMA1=0&TIMA2=0&s=BNO
Merck collaboration is interesting. Look at the cash hidden $20 M or $7.5 M not reported but it is there. Worst scenario $7.5 M added to $10 M already in hand.
Following it to see its interest with larger volume will dictate to put
 

Attachments

  • BNO PRESENTATION.pdf
    500.6 KB · Views: 17
Re: BNO - Bionomics


BNO is under trading halt today until 21st Sept pending announcement of Phase II trial of anxiety drug.
It is a strong buy so far from Morning Star. Three Directors have bought 100000 shares at a price around 28 cents early this month. Not a big figure but a good sign.
I am keeping my fingers crossed for a bang up to sell off my holding currently incurred 40% loss. I may recover some loss on my real investment with BNO and jump into top of ASF tipping ladder for sure, with a good news. However my gut feeling is market might have already factored that as I could see my stock tip on ASF went up top level and still achieved some 20% meaning no more rise unless too exciting trial news. I have held so far because of its fundamentals are strong still . Will be on air on 21st and can not check internet. Will see market movement on 22nd.
All the best who are holding or will be holding.
Hope I am not going to make a fire sell on 22nd
 
@Miner, all the best to you too.

Since reading up on BNO a few years ago, I especially like how and what this company does so have been watching for awhile, avoided rushing in at the 35c and beyond levels, watched the SP drift up and down and finally went long just recently @25c.

Did the Strong Buy signal sway me decision?
It helped although, I must admit, the prospect of blue sky is strong.

Will I hold short or long term?
Depends on what the halt is all about and what the SP does post announcement.

Having missed out on HIL at around the same price point not so long ago, whatever happens I do know I'd rather be in BNO than out at this stage.
 

Thanks Craton for adding up the list of strong buy consensus list and for me to hang on with BNO.
 
Had a quick look through this on the weekend, the company appears undervalued, however the red flag I see is management, there's a shareholder revolt and for very good reasons.. Undervalued stocks can remain in a value trap indefinitely until management unlocks it. I don't know much about BNO or what's happening with the trading halt, but the directors buying is definitely a good sign.
 
Thanks Craton for adding up the list of strong buy consensus list and for me to hang on with BNO.

Glad to be able to have an input


I suppose for traders it does seem that the company is out of favour plus, a large private placement sometime ago I think was the catalyst (can't seem to put my finger on that news) didn't help either.

Agree that that directors buying is a vote of confidence.
 
Share price collapse for BNO on Tuesday following the release of top-line data from the company's Phase 2 clinical trial of BNC210, a negative allosteric modulator of the α7 nicotinic acetylcholine receptor, in patients with Post Traumatic Stress Disorder (PTSD). The Trial did not meet the primary endpoint of a decrease in PTSD symptoms as measured by CAPS-5 at 12 weeks and the share price nose-dived as a result.

It appears to be currently consolidating between 15c and 20c. Oversold and possible bounce from here?

 
Honestly, for some reason just two days before the shocking news came to press, I got a premonition and sold out. I had burnt before with BNO but this time, left with chin up.
Some reasons, BNO has not struck gold with its testing outcome. I am unsure if in near future, they would have enough capital to dive again?
DNH any more
 
BNO bouncing back this morning after the company announced that an additional data analysis conducted in Sweden by Pharmetheus AB showed a statistically significant response when drug exposure versus response was measured in the Phase 2 PTSD Trial of its drug candidate BNC210.

It's got a large gap to fill between 20c and 45c and it should struggle with resistance at 20c but at least it is now heading in the right direction.

BNO up 58.3% to 19c so far today.

 
Probably a bit early to have a punt for the March Tipping Comp. but as noted, BNO on a bit of an uptick from recent lows.

From link: https://www.bionomics.com.au//upload/investors/announcements/4736/1899484.pdf

Further Data Analysis of Bionomics’ Phase 2 Post Traumatic Stress Disorder Trial Shows the Potential for Significant Patient Benefit When Drug Exposure is Adequate
  • Additional work undertaken on a drug exposure-response analysis shows a statistically significant response of BNC210 in treatment of PTSD symptoms, as measured by CAPS-5 at 12 weeks.
  • Bionomics will now seek FDA guidance on next steps for BNC210 for PTSD including the design of a further trial and whether BNC210 is eligible for Fast Track designation.
  • Variable absorption of the liquid formulation of BNC210 used in the PTSD trial and the requirement for the drug to be taken with food may be overcome through development of an improved solid dose formulation which has recently been evaluated in healthy human volunteers. The solid dose formulation of BNC210 is anticipated to be used in any future PTSD trials.
  • It is intended that the data from the ongoing BNC210 trial in Agitation will be analysed by dose and by measures of exposure given the PTSD trial learnings. Consequently, this trial is anticipated to read out in Q2, 2019
 
Which way mate? How did you know BNO is a SHE ??? Could be a Man, Woman or Trans
Up She, He, It pops... surely these are just idioms?


Good call Miner.
I see this as one of the closely followed and very volatile stocks that are worth the investment (cough, read punt) on the cycle. Always easy to say in low, out high but for me, this has been a great training stock as I don't have a preconceived holding strategy i.e. short, mid, long term. It's purely for trading when the opportunity presents.
 
Cookies are required to use this site. You must accept them to continue using the site. Learn more...